ZHBIO(SZ:300653)2023-12-14 08:25Group 1: Market Performance and Product Procurement - The company successfully participated in the collective procurement projects for its meningitis products in Jiangsu, Liaoning, and Shaanxi provinces, leading to a decrease in prices but an increase in sales volume [1] - The demand for dental implants has not met market expectations this year, influenced by the implementation of dental implant procurement policies [1] Group 2: Product Development and Research Progress - The transition verification work for active biological bone is nearing completion, with 2/3 of provinces having completed the online registration process [3] - The calcium silicate bioceramic bone repair material has completed nationwide clinical trial enrollment and is currently in the follow-up phase, with registration submission expected next year [4] - Other in-development products, including breast patches and uterine repair membranes, are also in the nationwide clinical trial enrollment stage [5] Group 3: Oral Product Procurement Status - The company's oral products, including oral repair membranes and bone repair materials, are currently not involved in collective procurement [2]